4 completed, 1 terminated, 1 unknown, 1 withdrawn. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Terminated 1, Unknown 1, Withdrawn 1 |
Follow palbociclib: new trials by email Literature Review of palbociclib trials Research Report on palbociclib
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical and Pharmacoeconomic Assessment of CDK4/6 Inhibitors for Treatment of Breast Cancer in Egypt Palbocicilib, Ribociclib, Abemaciclib - Breast Cancer | Phase 4 | Completed | Beni-Suef University | 206 | 2024-08-25 | 2026-03-23 |
| OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older Adults Olaparib, Lenvatinib, Sunitinib - Renal Cell Carcinoma, Ovarian Carcinoma | Phase 4 | Unknown | University Medical Center Groningen | 30 | 2024-05-01 | 2023-11-29 |
| Phase IV Multi-arm Study of CDK4/6 Pharmacokinetics in Healthy Volunteers With Known CYP3A4*22 Genotype Palbociclib 125Mg Tab, Ribociclib 200Mg Oral Tablet, Abemaciclib 150 MG Oral Tablet - CYP3A4*22 | Phase 4 | Withdrawn | University of Michigan Rogel Cancer Center | 2024-03-01 | 2024-02-02 | |
| Bioequivalence Study of Palbociclib 125 mg Capsules of Iclos vs. Ibrance (Palbociclib) Capsules 125 mg Palbociclib 125mg - Bioequivalence | Phase 4 | Completed | Megalabs | 24 | 2024-02-06 | 2024-08-19 |
| A Randomized, Open-label, Multi-center Phase IV Study Evaluating Palbociclib Plus Endocrine Treatment Versus a Chemotherapy-based Treatment Strategy in Patients With Hormone Receptor Positive / HER2 Negative Breast Cancer in a Real World Setting (GBG 93 - PADMA Study). Palbociclib / Chemotherapy (capecitabine, epirubicin, paclitaxel, vinorelbine) / Endocrine therapy (exemestane, fulvestrant, letrozole, tamoxifen) - Metastatic Breast Cancer | Phase 4 | Completed | GBG Forschungs GmbH | 130 | 2018-03-01 | 2024-10-01 |
| Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy Palbociclib, Fulvestrant, Anastrozole - Breast Neoplasm | Phase 4 | Terminated | Palleos Healthcare GmbH | 532 | 2017-07-24 | 2022-01-06 |
| Palbociclib In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR+, HER2- Advanced Breast Cancer Palbociclib, Letrozole - Breast Cancer | Phase 4 | Completed | Pfizer | 252 | 2016-03-09 | 2022-07-27 |
Breast Neoplasms (5) · Carcinoma, Renal Cell (1) · Endometrial Neoplasms (1) · Neoplasm Metastasis (1) · Ovarian Neoplasms (1) · Patient Acceptance of Health Care (1) · Thyroid Neoplasms (1)
Beni-Suef University (1) · GBG Forschungs GmbH (1) · Megalabs (1) · Palleos Healthcare GmbH (1) · Pfizer (1) · University Medical Center Groningen (1) · University of Michigan Rogel Cancer Center (1)
Germany (2) · India (2) · Australia (1) · Egypt (1) · Netherlands (1)
Daniel L Hertz (1) · Esther Broekman, MD (1) · Iris Reiser, PhD (1) · M Gowtham, MD (1) · Sibylle Loibl, MD, PhD (1)
2016 (1)